Advertisement

Topics

Endologix Announces Positive Clinical Results from the LEOPARD Clinical Study

08:00 EDT 17 Aug 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Endologix, Inc. (NASDAQ:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced positive interim results from the LEOPARD (Looking at Evar Outcomes by Primary Analysis of Randomized D...

Other Sources for this Article

Investors:
Endologix, Inc.
Vaseem Mahboob, 949-595-7200
CFO

NEXT ARTICLE

More From BioPortfolio on "Endologix Announces Positive Clinical Results from the LEOPARD Clinical Study"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Stent
A stent is a small mesh tube that's used to treat narrow or weak arteries. Arteries are blood vessels that carry blood away from your heart to other parts of your body.  A stent is placed in an artery as part of a procedure called angioplasty. &...

Acute Coronary Syndromes ACS
Acute Coronary Syndromes (ACS) is an umbrella term for situations where the blood supplied to the heart muscle is suddenly blocked. Treatment for acute coronary syndrome includes medicines and a procedure known as angioplasty, during which doctors inflat...